PT84182B - Novo retrovirus susceptivel de provocar o sida, meios e processos para a sua deteccao "in vitro" - Google Patents

Novo retrovirus susceptivel de provocar o sida, meios e processos para a sua deteccao "in vitro"

Info

Publication number
PT84182B
PT84182B PT84182A PT8418287A PT84182B PT 84182 B PT84182 B PT 84182B PT 84182 A PT84182 A PT 84182A PT 8418287 A PT8418287 A PT 8418287A PT 84182 B PT84182 B PT 84182B
Authority
PT
Portugal
Prior art keywords
susceptivel
vitro
media
processes
detection
Prior art date
Application number
PT84182A
Other languages
English (en)
Other versions
PT84182A (pt
Inventor
Luc Montagnier
Marianne Rey
Marc Alizon
Francois Clavel
Denise Guetard
Solange Chamaret
Francoise Brun-Vezinet
Christine Rouzioux
Christine Katlama
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27576220&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT84182(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR8600911A external-priority patent/FR2593190B1/fr
Priority claimed from FR8600910A external-priority patent/FR2593189B1/fr
Priority claimed from FR8601635A external-priority patent/FR2593922B1/fr
Priority claimed from FR8601985A external-priority patent/FR2594229B1/fr
Priority claimed from US06/835,228 external-priority patent/US4839288A/en
Priority claimed from FR8603881A external-priority patent/FR2596063B1/fr
Priority claimed from FR8604215A external-priority patent/FR2597500B1/fr
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of PT84182A publication Critical patent/PT84182A/pt
Publication of PT84182B publication Critical patent/PT84182B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/162—HIV-1, HIV-2 env, e.g. gp160, gp110/120, gp41, V3, peptid T, DC4-Binding site
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
PT84182A 1986-01-22 1987-01-22 Novo retrovirus susceptivel de provocar o sida, meios e processos para a sua deteccao "in vitro" PT84182B (pt)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
FR8600911A FR2593190B1 (fr) 1986-01-22 1986-01-22 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
FR8600910A FR2593189B1 (fr) 1986-01-22 1986-01-22 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
FR8601635A FR2593922B1 (fr) 1986-02-06 1986-02-06 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
FR8601985A FR2594229B1 (fr) 1986-02-13 1986-02-13 Nouveau retrovirus du type lav-ii susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
US06/835,228 US4839288A (en) 1986-01-22 1986-03-03 Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
FR8603881A FR2596063B1 (fr) 1986-03-18 1986-03-18 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
FR8604215A FR2597500B1 (fr) 1986-03-24 1986-03-24 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
US91608086A 1986-10-06 1986-10-06
US93318486A 1986-11-21 1986-11-21

Publications (2)

Publication Number Publication Date
PT84182A PT84182A (pt) 1987-02-01
PT84182B true PT84182B (pt) 1989-09-14

Family

ID=27576220

Family Applications (1)

Application Number Title Priority Date Filing Date
PT84182A PT84182B (pt) 1986-01-22 1987-01-22 Novo retrovirus susceptivel de provocar o sida, meios e processos para a sua deteccao "in vitro"

Country Status (15)

Country Link
EP (2) EP0320495B1 (pt)
JP (7) JP2611106B2 (pt)
AR (1) AR243931A1 (pt)
AT (2) ATE195148T1 (pt)
AU (1) AU601397B2 (pt)
DE (3) DE239425T1 (pt)
DK (2) DK175959B1 (pt)
ES (1) ES2150897T3 (pt)
GR (3) GR880300056T1 (pt)
HK (1) HK62091A (pt)
NZ (1) NZ219024A (pt)
OA (1) OA08468A (pt)
PT (1) PT84182B (pt)
SG (1) SG28591G (pt)
WO (1) WO1987004459A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002892A1 (en) * 1985-11-14 1987-05-21 President And Fellows Of Harvard College T-lymphotrophic virus
ATE417108T1 (de) * 1987-01-16 2008-12-15 Pasteur Institut Hiv-2 und siv-1 nukleotidsequenzen
AU608294B2 (en) * 1987-01-16 1991-03-28 Institut Pasteur Peptides having immunological properties 2-hiv-2
EP0287226A1 (en) * 1987-03-23 1988-10-19 Hiver Limited Novel vaccines
SE8701765L (sv) * 1987-04-28 1988-10-29 Statens Bakteriologiska Lab Analysmetod och medel foer denna
US4812556A (en) * 1987-05-18 1989-03-14 Virovahl Synthetic peptide antigen for the detection of HIV-2 infection
FR2620030B1 (fr) * 1987-09-07 1990-03-23 Transgene Sa Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus
US5780038A (en) * 1987-11-16 1998-07-14 Roche Diagnostic Systems, Inc. HIV-2 envelope polypeptides
DE3879881D1 (de) * 1987-11-16 1993-05-06 Hoffmann La Roche Rekombinante hiv-2 polypeptide.
AU3063389A (en) * 1988-01-08 1989-08-01 Dpz Deutsches Primatenzentrum Gesellschaft M.B.H. Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
WO1989009815A1 (en) * 1988-04-04 1989-10-19 Research Corporation Technologies, Inc. Novel virus of the hiv-2 family and methods of detection therefor
US5208321A (en) 1988-06-09 1993-05-04 Institut Pasteur HIV-2 transmembrane glycoprotein homodimer (GP 80)
EP0657532B1 (en) 1988-06-09 2003-12-17 N.V. Innogenetics S.A. HIV-3 retrovirus strains and their use
US6197496B1 (en) 1988-06-09 2001-03-06 Institut Pasteur Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80
EP0345559A3 (en) * 1988-06-10 1990-07-11 Abbott Laboratories Hiv-2 variants
EP0347365B1 (en) † 1988-06-14 1996-08-28 QIAGEN GmbH HIV-2 virus variants
SG48125A1 (en) * 1989-05-12 1998-04-17 Pasteur Institut Antigenes of the envelope transmembrance glcoprotein of a human retrovirus of the hiv-2 type and antigens presenting with them an immunological relationship
FR2646854A1 (fr) * 1989-05-12 1990-11-16 Pasteur Institut Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 antigenes presentant avec eux une parente immunologique
ATE131731T1 (de) * 1989-05-31 1996-01-15 Pasteur Institut Hiv-2-eho-retrovirus-proteine und -glycoproteine, antikörper gegen sie, verwendung für diagnostische zwecke
FR2647810B1 (fr) * 1989-06-02 1994-07-22 Pasteur Institut Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
DE69034220T2 (de) 1989-06-02 2006-12-28 Institut Pasteur Nukleotid-Sequenzen von HIV-1, HIV-2 and SIV Retrovirusgenommen, ihre Verwendung zur Amplifizierung von diesen Retrovieren und zur in vitro Diagnostik von diesen Viren verursachten Infektion
US7022814B1 (en) 1992-01-21 2006-04-04 Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
FR2647809B1 (fr) * 1989-06-02 1991-09-20 Pasteur Institut Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
EP0438332B1 (fr) * 1990-01-16 1998-04-08 Orgenics Ltd. Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA
ES2053014T5 (es) * 1990-06-15 2001-02-16 Innogenetics Nv El retrovirus sivcpz-ant y sus usos.
GB9108652D0 (en) * 1991-04-23 1991-06-12 Antisoma Ltd Immunoreactive compounds
AU677225B2 (en) * 1992-10-06 1997-04-17 Dade Behring Marburg Gmbh Retrovirus from the HIV group and its use
DE4233646C2 (de) * 1992-10-06 2003-10-23 Dade Behring Marburg Gmbh Retrovirus aus der HIV-Gruppe und dessen Verwendung
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US5962665A (en) 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
FR2767337B1 (fr) 1997-08-14 2002-07-05 Pasteur Institut Sequences nucleiques de polypeptides exportes de mycobacteri es, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose
DE60132924T2 (de) 2000-10-23 2009-03-05 Gen-Probe Inc., San Diego Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
EP2251442B9 (en) 2003-12-19 2012-04-25 Gen-Probe Incorporated Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2
JP6721772B1 (ja) 2019-03-26 2020-07-15 斉藤　幹雄 清掃装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652599A (en) * 1984-04-23 1987-03-24 The United States Of America As Represented By The Department Of Health And Human Services Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS using permissive cells
NZ230372A (en) * 1984-10-18 1994-02-25 Pasteur Institut Hiv antigen, assay and vaccine.
US4600413A (en) * 1984-12-10 1986-07-15 Sundstrand Corporation Centrifugal deaerator and pump
JP3105581B2 (ja) * 1991-07-03 2000-11-06 内橋エステック株式会社 面状温度ヒュ−ズ

Also Published As

Publication number Publication date
GR880300056T1 (en) 1988-10-18
EP0239425A1 (fr) 1987-09-30
DE3752319D1 (de) 2000-09-07
JPH08275783A (ja) 1996-10-22
GR3001096T3 (en) 1992-04-17
DK175959B1 (da) 2005-08-29
JPH08113598A (ja) 1996-05-07
PT84182A (pt) 1987-02-01
JP2735521B2 (ja) 1998-04-02
JPH0975092A (ja) 1997-03-25
JP2801162B2 (ja) 1998-09-21
EP0320495B1 (fr) 2000-08-02
DK200500170A (da) 2005-02-04
ES2150897T3 (es) 2000-12-16
NZ219024A (en) 1990-04-26
DE3760912D1 (en) 1989-12-07
JPH06113833A (ja) 1994-04-26
WO1987004459A1 (fr) 1987-07-30
DK493487A (da) 1987-11-17
JPH07233196A (ja) 1995-09-05
EP0239425B1 (fr) 1989-11-02
GR3034708T3 (en) 2001-01-31
JPH1118768A (ja) 1999-01-26
OA08468A (fr) 1988-07-29
AR243931A1 (es) 1993-09-30
JP2874846B2 (ja) 1999-03-24
JPH0937778A (ja) 1997-02-10
AU601397B2 (en) 1990-09-13
JP2611106B2 (ja) 1997-05-21
AU6891187A (en) 1987-08-14
EP0320495A1 (fr) 1989-06-14
JP2771519B2 (ja) 1998-07-02
JP2931294B2 (ja) 1999-08-09
ATE195148T1 (de) 2000-08-15
DE239425T1 (de) 1988-06-30
DE3752319T2 (de) 2001-03-15
ATE47725T1 (de) 1989-11-15
HK62091A (en) 1991-08-16
DK493487D0 (da) 1987-09-21
SG28591G (en) 1993-02-19
DK176253B1 (da) 2007-04-30

Similar Documents

Publication Publication Date Title
PT84182B (pt) Novo retrovirus susceptivel de provocar o sida, meios e processos para a sua deteccao "in vitro"
MX161924A (es) Mejoras en diafragma para bombas y similares
DE69012423D1 (de) Fälschungssichere Etikette.
DE3671839D1 (de) Direkttablettierhilfsmittel.
BR8606825A (pt) Corantes reativos,sua preparacao e emprego
DE3782898D1 (de) Kraft- und moment-messfuehler.
DE3675344D1 (de) Geschlossene breit-nip-presse.
DE3687729D1 (de) Papierherstellungsverfahren.
BR8601035A (pt) Macroemulsoes,processo para sua preparacao e emprego
BR8904404A (pt) Poliorganosiloxano,processo de sua preparacao,e,elastomeros
BR8704828A (pt) Plastisois,processo para sua preparacao e emprego
BR8603494A (pt) Poliesteraminas oxalquiladas,processo para a sua obtencao e sua utilizacao
NO865255D0 (no) Filterpresse.
BR8502707A (pt) 1,3-oxazolidina-2-ona derivados e processo para sua preparacao
NO865152D0 (no) Papirmaskinbane og lignende.
BR8600541A (pt) Material de suporte para chapas de impressao"offset",processo para sua obtencao e utilizacao
KR880700853A (ko) Aids를 유발시킬수 있는 신규 레트로비루스와 실험관내에서 그것을 검출하기 위한 수단 및 방법
NO900025D0 (no) Pyrrolylfenyl-substituerte hydroksamsyrederivater.
BR8806332A (pt) Pigmentos monoazoicos,processo para sua preparacao e sua aplicacao
NO863153D0 (no) Papirmaskinbane og lignende toey.
IT1243739B (it) L-carnitina deidrogenasi e procedimento per la sua produzione.
IT1208416B (it) Preparato di sucralfato e procedimento per la sua produzione
IT1238207B (it) Preparato vitaminizzato contenente l'enzima lisozima impiegabile in zootecnica e procedimento per la sua produzione.
BR8805857A (pt) Poliazocorantes,processo para sua preparacao e utilizacao
IT8447939A1 (it) Procedimento per assicurare l'identificazione di campioni, e registro di campioni per la sua applicazione.